Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA® (pembrolizumab) as First-Line Treatment for PD-L1-Positive NSCLC Met Primary Endpoint 2025-11-24 20:00
Beyfortus® (nirsevimab) now available in Malaysia to protect all infants against RSV disease 2025-11-24 16:55
GenEditBio and ToolGen Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics 2025-11-24 08:00
Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up 2025-11-22 20:28
Global Health Leaders Convene in Kuala Lumpur from 25-27 November for Malaysia International Healthcare Megatrends 2025 2025-11-22 02:05
Hong Kong hosts landmark International Genomic Medicine Symposium 2025-11-21 15:49
Telix Opens TMS Yokohama in Japan, Commemorative Lecture Held 2025-11-21 14:22
NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward 2025-11-21 13:46
Everest Medicines Announces First Patient Dosed in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14 2025-11-21 12:01
Henlius' Serplulimab (anti-PD-1 mAb) Granted Breakthrough Therapy Designation by China NMPA for Neo-/Adjuvant Treatment for Gastric Cancer 2025-11-20 18:52
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry 2025-11-20 10:00
ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses 2025-11-20 03:00
Lynk Pharmaceuticals Announces Key Phase II Clinical Results of LNK01004 for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis 2025-11-19 08:00
Ajinomoto Bio-Pharma Services Wins "Best ADC Preclinical Publication 2024" Award for AJICAP® Technology at 2025 World ADC Awards 2025-11-17 22:26
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US 2025-11-17 22:06
Lundbeck files for marketing authorization across key Asian markets for Vyepti® (eptinezumab) for the preventive treatment of migraine 2025-11-14 17:43
Fosun International Receives "ESG & Corporate Sustainability Excellence Award" from Hong Kong Economic Journal 2025-11-14 09:00
Herbalgy Unveils a New Campaign Featuring Cecilia Yeung in Conversation with Professor Wong Tin Chee Introducing Touch-Cool 5 ml Portable Edition and the New Herbalgy Analgesic Plaster 2025-11-14 09:00
HKSH Medical Group Hosts Hong Kong's First Asia-Oceania Particle Therapy Co-operative Group Conference 2025-11-13 19:22
Project ACTIVE 2.0 Strengthens Global Collaboration to Advance Cervical Cancer Care in Southeast Asia 2025-11-13 15:40
1 2 3 4 5 280